<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="343432">
  <stage>Registered</stage>
  <submitdate>10/09/2011</submitdate>
  <approvaldate>14/09/2011</approvaldate>
  <actrnumber>ACTRN12611000980932</actrnumber>
  <trial_identification>
    <studytitle>Whether the antioxidants can prevent patients with obstructive jaundice from the hypotension in operation.</studytitle>
    <scientifictitle>Compared with controls ,whether the treatment of antioxidants can alleviate vascular hyporesponsiveness in patients with obstructive jaundice</scientifictitle>
    <utrn>U1111-1124-2612</utrn>
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>obstructive jaundice</healthcondition>
    <healthcondition>vascular hyporesponsiveness</healthcondition>
    <conditioncode>
      <conditioncode1>Cardiovascular</conditioncode1>
      <conditioncode2>Diseases of the vasculature and circulation including the lymphatic system</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Other anaesthesiology</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Oral and Gastrointestinal</conditioncode1>
      <conditioncode2>Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Glutathione reduced by Intravenous injection,240mg,every day,7 days before abdominal operation</interventions>
    <comparator>intravenous saline injection</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>blood pressure from radial artery cannula</outcome>
      <timepoint>every 5 minutes for the duration of the operation</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>pulmonary arterial wedge pressure from pulmonary artery balloon flow catheter(Swan-ganz catheter)</outcome>
      <timepoint>every 5 minutes for the duration of the operation</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>heart rate from monitor</outcome>
      <timepoint>every 5 minutes for the duration of the operation</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>the expression of alpha-advenergic receptors protein on mesenteric artery by Westen blot</outcome>
      <timepoint>immediately after operation</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>mRNA expressing alpha-advenergic receptors on mesenteric artery by Real time PCR(Polymerase chain reaction)</outcome>
      <timepoint>immediately after operation</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>participants with obstructive jaundice(serum total bilirubin&gt;100umol/L)caused by neoplasm of the bile duct or the head of the pancreas who will undergo abdominal operation</inclusivecriteria>
    <inclusiveminage>50</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>70</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Males</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>females,&lt;50 years &gt;70 years,BMI&gt;30kg/m2 &lt;18kg/m2,diabetes,cardiovascular diseases</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>central randomisation by computer</concealment>
    <sequence>simple randomisation using a randomisation table created by computer</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>15/10/2011</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>80</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>China</country>
      <state>Shanghai</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Department of Anesthesiology,Easten Hepatobiliary Hospital</primarysponsorname>
    <primarysponsoraddress>225 Changhai Road
Yangpu District
Shanghai China
200438</primarysponsoraddress>
    <primarysponsorcountry>China</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>National Natural Science Foundaton of China</fundingname>
      <fundingaddress>83 Shuangqing Road
Haidian District
Beijing China
100085</fundingaddress>
      <fundingcountry>China</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Weifeng Yu PhD.MD.</sponsorname>
      <sponsoraddress>Department of Anesthesiology,Easten Hepatobiliary Surgery Hospital
225 Changhai Road
Yangpu District
Shanghai China
200438</sponsoraddress>
      <sponsorcountry>China</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>1.Vascular hyporesponsiveness in patients with obstructive jaundice is a common problem during operation. It causes high complication and high mortality during preoperative period. But the mechanism is still unknown. There is still no effective method to prevent and treat vascular hyporesponsiveness.
2.Patients with obstructive jaundice produce great amount of Recative Oxygen Species(ROS). The excessive ROS seem to have two effects on blood vessel by the a-advenergic receptors(a-AR). The acute and short-term effect changes the expression, affinity, phosphorylation level of a-AR and cause the decreased contractility of blood vessel. The chronic and long-term effect causes the remodeling of blood vessel by a-AR signal pathway through cell hypertrophy, hyperplasia and apoptosis. These two effects may result in vascular hyporesponsiveness.
3.Therefore, the present research focuses on the vascular hyporesponsiveness in patients with obstructive jaundice caused by ROS through a-AR.  The research may put forward feasible explanations of unstable haemodynamics in obstructive jaundice patients. It may also offer a new target to prevent and treat the unstable haemodynamics to increase the preoperative safety in obstructive jaundice patients.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Not yet submitted</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>The Ethics Committee of The Second Military Medical University</ethicname>
      <ethicaddress>800 Xiangyin Road
Yangpu District
Shanghai China
200433</ethicaddress>
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate>1/09/2011</ethicsubmitdate>
      <ethiccountry>China</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Weifeng Yu.PhD.MD.</name>
      <address>Department of Anesthesiology,Easten Hepatobiliary Surgery Hospital
225 Changhai Road
Yangpu District
Shanghai China
200438</address>
      <phone>86 013901961704</phone>
      <fax>+86 021 65564166</fax>
      <email>ywf808@sohu.com</email>
      <country>China</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Jiaying Chen .MD.</name>
      <address>Department of Anesthesiology,Easten Hepatobiliary Surgery Hospital
225 Changhai Road
Yangpu District
Shanghai China
200438</address>
      <phone>+86 015850557096</phone>
      <fax>+86 021 65564166</fax>
      <email>willde.pchome@yahoo.com.cn</email>
      <country>China</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Jiaying Chen .MD.</name>
      <address>Department of Anesthesiology,Easten Hepatobiliary Surgery Hospital
225 Changhai Road
Yangpu District
Shanghai China
200438</address>
      <phone>+86 015850557096</phone>
      <fax>+86 021 65564166</fax>
      <email>willde.pchome@yahoo.com.cn</email>
      <country>China</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>